Unknown PHASE3 INTERVENTIONAL 2-arm NCT00628680

A Multi-Centered, Two-Arm, Randomized Study Comparing the Effects of AAT-023 (Zuragen) Solution, and Heparin on the Incidence of Catheter Related Blood Stream Infections in Tunneled Chronic Central Venous Catheters for Dialysis

Pivotal/Phase III Multicentered, Two-Arm, Randomized Study Comparing the Effects of AAT-023 Solution (Zuragen), and Heparin on the Incidence of Catheter Related Blood Stream Infections in Tunneled Chronic Central Venous Catheters for Dialysis

Sponsor: Ash Access Technology

Conditions End Stage Renal Disease

Interventions AAT-023 solution (Zuragen) Heparin

Updated 6 times since 2017 Last updated: Mar 4, 2008 Started: Jul 31, 2006 Primary completion: Jul 31, 2008

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This PHASE3 trial investigates End Stage Renal Disease and is currently ongoing. Ash Access Technology leads this study, which shows 6 recorded versions since 2006 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

6 versions recorded

Sep 2024 — Present [monthly]

Unknown PHASE3
Jul 2024 — Sep 2024 [monthly]

Unknown PHASE3

Status: Unknown Status → Unknown
Jan 2021 — Jul 2024 [monthly]

Unknown Status PHASE3
Jun 2018 — Jan 2021 [monthly]

Unknown Status PHASE3
Feb 2017 — Jun 2018 [monthly]

Unknown Status PHASE3

▶ Show 1 earlier version

Jan 2017 — Feb 2017 [monthly]

Unknown Status PHASE3

First recorded

Jul 2006

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Ash Access Technology

Data source: Ash Access Technology

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

Appelton, United States , Augusta, United States , Bakersfield, United States , Baltimore, United States , Boston, United States , Brandon, United States , Buffalo, United States , Detroit, United States , Dunedin, United States , Erie, United States and 10 more locations